Showing results (21-30 of 747) with videos related to
Sort By:
Pageof 75
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2011
Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaireArchna Bajaj, Bernard Rosner, Steven W Lockley, et al.Pharmacological Research|July 17, 2023
Recent advances in the management and implementation of care for familial hypercholesterolaemiaNick S R Lan, Archna Bajaj, Gerald F Watts, et al.Journal of the American Heart Association|March 8, 2024
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of InclisiranMichael J Wilkinson, Archna Bajaj, Margaret E Brousseau, et al.Journal of Clinical Lipidology|August 8, 2025
Pelacarsen: Mechanism of action and Lp(a)-lowering effectHarpreet S Bhatia, Archna Bajaj, Sascha N Goonewardena, et al.Journal of Clinical Lipidology|September 25, 2024
Real-world experience of inclisiran prescription at the University of Pennsylvania Health SystemsNicole M Wei, Robert F Tobin, Douglas S Jacoby, et al.Journal of Cardiopulmonary Rehabilitation|April 18, 2006
High-density lipoprotein cholesterol therapies: the next frontier in lipid managementDanielle Duffy, Daniel J RaderCurrent Opinion in Cardiology|June 16, 2005
Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J RaderClinical Chemistry|April 1, 2008
Laboratory assessment of HDL heterogeneity and functionRajesh Movva, Daniel J RaderNature Reviews. Endocrinology|September 3, 2014
Dyslipidaemia: cardiovascular prevention--end of the road for niacin?Sony Tuteja, Daniel J RaderThe Lancet. Diabetes & Endocrinology|March 26, 2016
Recent advances in the pharmacological management of hypercholesterolaemiaEzim Ajufo, Daniel J RaderPageof 75